A vaccine against coronavirus, being developed together by scientists at the University of Oxford and pharma giant AstraZeneca, may be cleared by health regulators by the end of this year, according to a UK media report. The vaccine candidate is the furthest in the process of trials, according to a report in The Times quoting British government sources. "We are looking at closer to six months and it is likely to be far shorter than that," one such source said.